StonvexLoading…
StonvexStonvexStonvexCore line items from JHG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $690.00M | $3.10B | $1.96B | $1.25B |
Operating Income | $113.90M | $976.80M | $489.40M | $317.40M |
Net Income | $90.90M | $815.90M | $412.70M | $270.60M |
EPS (Diluted) | $0.59 | $5.23 | $2.63 | $1.72 |
Total Assets | $7.80B | $8.29B | $7.61B | $7.45B |
Total Liabilities | $2.08B | $2.17B | $1.94B | $1.81B |
Cash & Equivalents | $1.38B | $1.25B | $996.90M | $882.60M |
Free Cash Flow OCF − CapEx | $231.60M | $710.90M | $390.50M | $134.10M |
Shares Outstanding | 154.08M | 154.08M | 154.68M | 156.21M |